Multiple studies demonstrated that PPARγ shifts far away from liver tissues by regulating downstream genes, reducing triglyceride accumulation in cells, and increasing cholesterol efflux, resulting in the inhibition of hepatic tissue steatosis and amelioration of hepatocellular injury (Li et al., 2021; Ma et al., 2022; Wei & Huang, 2019). This evidence concerns the gene PPARG and steatosis.